We also found that cell cycle, pathways in cancer, Hippo signaling pathway and Wnt signaling pathway were associated with KRAS mutation, TP53 mutation or CDKN2A deletion in pancreatic cancer (Figure 3C). The gene discussed is CDKN2A; the disease is familial pancreatic carcinoma.